Categories AlphaGraphs, Earnings, Health Care
A visual representation of Pfizer Inc. (NYSE: PFE) Q1 2020 earnings results
Pfizer Inc. (NYSE: PFE) Tuesday reported a decline in first-quarter earnings and revenues. However, the results exceeded analysts’ forecast.
Earnings, on an adjusted basis, dropped to $0.80 per share from $0.85 per share in the first quarter of 2019. The pharma company reported unadjusted profit of $3.4 billion or $0.61 per share for the three-month period, down from last year’s $3.88 billion or $0.68 per share. Earnings, meanwhile, came in above the estimates.
The weakens in the bottom-line performance is attributable to a 8% decline in revenues to $12 billion. Analysts were looking for a slightly lower number.
Shares of Pfizer closed the last trading session higher and continued to gain during Tuesday’s pre-market session. The stock has declined 7% in the past twelve months.
[irp posts=”54121″]
Most Popular
BLK Q4 Preview: BlackRock appears poised for another earnings beat
BlackRock, Inc. (NYSE: BLK), the largest asset management company, is expected to publish its fourth-quarter 2025 results next week. The update is expected to shed light on how the firm’s
A look at Best Buy’s (BBY) progress on its growth strategy
Shares of Best Buy Co., Inc. (NYSE: BBY) fell over 3% on Wednesday. The stock has dropped 17% over the past 12 months. The consumer electronics retailer delivered sales and
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
